With a background that includes both science and finance, Kimi has carefully crafted a financial strategy that has allowed Sage to remain a nimble, independent, and innovative biopharmaceutical company. She joined Sage as CFO in 2013, bringing financial and operating strength from her senior management experiences at established, and emerging, life science companies. Prior to joining Sage, Kimi served as Chief Operating Officer, North America, for Santhera Pharmaceuticals, and Vice President of Finance at Cyberkinetics Neurotechnology Systems. Previously, Kimi held roles of increasing responsibility at Millennium Pharmaceuticals and Biogen. She also worked as a business assurance manager at PricewaterhouseCoopers LLP and began her career in chemistry-related positions at various Boston-based companies.
Kimi holds a B.A. in chemistry from Drew University and an M.B.A. from Northeastern University. She earned her CPA in Massachusetts.